Bregua Corp

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Klaus Dorner, Director of Bregua Corporation
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bregua Corp:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. 10%+ Owner Common Stock 3,749,250 $22,008,098 $5.87 15 Jun 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 15 Jun 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 15 Jun 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series Seed 2 Convertible Preferred Stock 0 15 Jun 2021 Direct
Janux Therapeutics, Inc. 10%+ Owner Series Seed Convertible Preferred Stock 0 15 Jun 2021 Direct

Insider Reports Filed by Bregua Corp

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 15 Jun 2021 9 +$999,991 4 10%+ Owner 16 Jun 2021, 18:22
JANX Janux Therapeutics, Inc. 10 Jun 2021 0 $0 3 10%+ Owner 10 Jun 2021, 19:32